StonvexLoading…
StonvexStonvexStonvexCore line items from STX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-27 | Annual 2024 2024-06-28 | Annual 2023 2023-06-30 | Annual 2022 2022-07-01 |
|---|---|---|---|---|
Revenue | $9.10B | $6.55B | $7.38B | $11.66B |
Operating Income | $1.89B | $452.00M | $-342.00M | $1.96B |
Net Income | $1.47B | $335.00M | $-529.00M | $1.65B |
EPS (Diluted) | $6.77 | $1.58 | $-2.56 | $7.36 |
Total Assets | $8.02B | $7.74B | $7.56B | $8.94B |
Total Liabilities | $8.48B | $9.23B | $8.76B | $8.84B |
Cash & Equivalents | $891.00M | $1.36B | $786.00M | $615.00M |
Free Cash Flow OCF − CapEx | $818.00M | $664.00M | $626.00M | $1.28B |
Shares Outstanding | 212.67M | 210.18M | 207.39M | 209.85M |